The Company

Medleaf is a pioneering and innovative company, active in the fields of import and distribution of medical devices specializing in Thalassaemia.

One of the fundamental therapies for treating Thalassaemia is based on iron-chelation drugs administered subcutaneously through an infusion pump. The pump binds the iron and allows it to be eliminated.

The goal is to keep the body’s iron levels below the toxicity threshold, improving the quality of life and life expectancy of patients.

Medleaf has a wide range of infusion sets and pumps to meet individual needs.